AbbVie Inc. (NYSE:ABBV)

The financial trajectory between 2021 and 2025 is characterized by a period of significant operating volatility, resulting in a cycle of economic value destruction followed by a gradual recovery toward positive economic profit.

Net Operating Profit After Taxes (NOPAT)

A severe contraction in NOPAT is observed between 2022 and 2023, with values dropping from 11,543 million US$ to 3,292 million US$. Following this trough, a steady recovery trend is evident, with NOPAT increasing to 4,563 million US$ in 2024 and further reaching 5,919 million US$ by 2025.

Cost of Capital

The cost of capital demonstrates a consistent upward trend over the five-year period, rising from 8.01% in 2021 to 8.92% in 2025. This incremental increase indicates a rising hurdle rate, which puts additional pressure on the company to generate higher operating returns to create value.

Invested Capital

A sustained downward trend in invested capital is noted, decreasing from 95,922 million US$ in 2021 to 61,356 million US$ in 2025. This reduction in the capital base serves to lower the total capital charge, partially offsetting the impact of the rising cost of capital.

Economic Profit

Economic profit shifted from positive values in 2021 and 2022 to a significant deficit in 2023, where it reached -2,676 million US$. While the figure remained negative in 2024 at -1,531 million US$, a return to positive economic profit was achieved in 2025 with a value of 445 million US$. This recovery indicates that the growth in NOPAT and the reduction in invested capital eventually overcame the increasing cost of capital.

Net earnings attributable to AbbVie Inc. exhibited an initial increase from 2021 to 2022, followed by a substantial decline in 2023 and a slight recovery in 2024 and 2025. However, the trend in net operating profit after taxes (NOPAT) presents a different pattern. NOPAT decreased from 2021 to 2023, then increased significantly in 2024 and 2025.

NOPAT Trend

NOPAT began at US$12,362 million in 2021, decreasing to US$11,543 million in 2022, representing a decline of approximately 6.7%. A more pronounced decrease occurred in 2023, with NOPAT falling to US$3,292 million. This represents a substantial reduction of over 71% from the 2022 value. A recovery is then observed in 2024, with NOPAT rising to US$4,563 million, and continuing upward in 2025 to reach US$5,919 million. The 2025 value, while representing a significant improvement from 2023, remains below the levels seen in 2021 and 2022.

The divergence between the trends in net earnings and NOPAT suggests potential shifts in the company’s capital structure or non-operating items. While net earnings decreased significantly in 2023, the NOPAT decline was even more substantial, indicating that factors beyond core operating profitability contributed to the reduction in net income. The subsequent recovery in NOPAT, exceeding the recovery in net earnings, suggests improvements in operational efficiency or changes in the cost of capital may be influencing the results.

Relationship between NOPAT and Net Earnings

In 2021 and 2022, NOPAT was consistently higher than net earnings attributable to AbbVie Inc. However, this relationship changed in 2023 and 2024, where net earnings exceeded NOPAT. By 2025, net earnings and NOPAT were relatively close, but net earnings remained slightly higher. This difference could be attributed to items such as interest expense, taxes, and other non-operating income or expenses.

The substantial fluctuations in NOPAT warrant further investigation to understand the underlying drivers. A detailed analysis of the components of NOPAT, including operating revenue, operating expenses, and tax rates, would be necessary to pinpoint the specific factors contributing to these changes.

The reported income tax expense and cash operating taxes exhibit distinct trends over the five-year period. Income tax expense fluctuates considerably, while cash operating taxes generally increase, though with notable variations.

Income Tax Expense

Income tax expense increased from US$1,440 million in 2021 to US$1,632 million in 2022, representing a rise of approximately 13.3%. A subsequent decrease was observed in 2023, with expense falling to US$1,377 million. A significant shift occurred in 2024, resulting in a tax benefit of US$570 million. This was followed by a substantial increase in expense to US$2,364 million in 2025. The volatility suggests potential impacts from changes in tax laws, deferred tax asset adjustments, or significant shifts in pre-tax income.

Cash Operating Taxes

Cash operating taxes demonstrate an overall upward trend, although not consistently. The amount rose from US$2,843 million in 2021 to US$3,997 million in 2022, an increase of approximately 40.6%. Further growth was seen in 2023, reaching US$4,625 million. A considerable decline occurred in 2024, with cash taxes decreasing to US$1,339 million. The final year, 2025, shows a recovery to US$3,414 million. The fluctuations in cash taxes are likely influenced by timing differences between income tax expense and actual cash payments, as well as potential tax planning strategies.

Relationship between Income Tax Expense and Cash Operating Taxes

A divergence is apparent between the two measures. While income tax expense is reported on the income statement based on accounting standards, cash operating taxes reflect the actual cash outflows for taxes. The significant difference in 2024, where an income tax benefit is recorded alongside a cash outflow, indicates substantial deferred tax impacts or tax credits being utilized. The generally higher level of cash taxes compared to income tax expense throughout the period suggests the company may be utilizing tax loss carryforwards or experiencing temporary differences that result in higher cash payments than reported expense.

The observed patterns warrant further investigation into the underlying drivers of these fluctuations, particularly the significant changes in 2024 and 2025, to fully understand their implications for the company’s financial position and future cash flows.

The reported invested capital demonstrates a declining trend over the five-year period. Total reported debt & leases and stockholders’ equity both contribute to the calculation of invested capital, and changes in these components influence the overall trend.

Invested Capital Trend

Invested capital decreased from US$95,922 million in 2021 to US$61,356 million in 2025. The most significant decrease occurred between 2022 and 2023, falling from US$82,134 million to US$68,204 million. A smaller decrease was observed between 2021 and 2022. A slight increase occurred between 2023 and 2024, followed by a further decrease in 2025.

Debt & Leases

Total reported debt & leases decreased from US$77,575 million in 2021 to US$64,191 million in 2022, continuing to US$60,286 million in 2023. An increase to US$68,019 million was noted in 2024, followed by a marginal increase to US$68,379 million in 2025. While fluctuating, the level of debt remained relatively stable between 2024 and 2025.

Stockholders’ Equity

Stockholders’ equity increased from US$15,408 million in 2021 to US$17,254 million in 2022. However, a substantial decline was observed in subsequent years, decreasing to US$10,360 million in 2023, US$3,325 million in 2024, and ultimately reaching a deficit of US$-3,270 million in 2025. This negative equity position in the final year represents a significant shift.

The decrease in invested capital appears to be primarily driven by the substantial reduction in stockholders’ equity, particularly in the later years of the period. While debt levels decreased initially, they stabilized and even increased slightly in the most recent years, suggesting that debt reduction is not the primary driver of the overall decline in invested capital. The transition to negative stockholders’ equity in 2025 is a notable development that warrants further investigation.

The financial performance over the analyzed five-year period indicates a significant shift from value creation to value destruction, followed by a marginal recovery. The transition is characterized by a sharp contraction in economic profit and a volatile economic spread ratio, coinciding with a steady reduction in the overall capital base.

Economic Spread Ratio

A peak in the economic spread ratio was observed in 2022 at 5.50%, followed by a substantial collapse to -3.92% in 2023. This negative spread persisted through 2024 at -2.21%, signifying a period where the return on invested capital failed to meet the cost of capital. A modest recovery occurred in 2025, with the ratio returning to a positive 0.73%.

Economic Profit

Economic profit mirrored the spread ratio, moving from a strong positive of 4,676 million US$ in 2021 to a deficit of 2,676 million US$ in 2023. Although the deficit was reduced to 1,531 million US$ in 2024, the company only returned to positive economic profit in 2025, recording 445 million US$.

Invested Capital

A consistent downward trend in invested capital is evident, decreasing from 95,922 million US$ in 2021 to 61,356 million US$ in 2025. Aside from a slight increase in 2024 to 69,263 million US$, the sustained reduction suggests a strategic contraction of the asset base or significant depreciation and divestment activities.

The financial trajectory from 2021 to 2025 is characterized by a significant volatility in value creation, marked by a severe contraction in economic profit followed by a gradual recovery phase. While net revenues remained relatively resilient throughout the period, the economic profit margin experienced a sharp decline into negative territory before returning to a positive state by the end of the analyzed period.

Economic Profit Trends

A substantial decline is observed between 2021 and 2023, where economic profit dropped from US$ 4,676 million to a deficit of US$ 2,676 million. This indicates a period where the return on capital failed to cover the cost of capital. A recovery trend began in 2024, with the deficit narrowing to US$ 1,531 million, eventually returning to a positive value of US$ 445 million by December 31, 2025.

Net Revenue Performance

Net revenues exhibited a non-linear but generally upward trajectory. After a slight increase in 2022 to US$ 58,054 million, a dip occurred in 2023 to US$ 54,318 million. However, the subsequent years show consistent growth, reaching a peak of US$ 61,160 million in 2025. The stability of revenues suggests that the volatility in economic profit was driven more by capital costs or operational efficiencies than by a fundamental collapse in sales.

Economic Profit Margin Analysis

The economic profit margin mirrors the volatility of the absolute economic profit. Starting at 8.32% in 2021, the margin contracted to 7.78% in 2022 before plummeting to -4.93% in 2023. The subsequent recovery to -2.72% in 2024 and 0.73% in 2025 indicates a successful, albeit slow, restoration of value creation. The return to a positive margin in 2025 signifies that the organization has once again begun generating returns in excess of its cost of capital.